Table 4

Guideline compliance

ESC/EAS guideline criteria 9n/N (%)
ASCVD and LDL-C not at goal & max. tolerated statin dose79/200 (39.5)
ASCVD and statin intolerance (three statins)127/200 (63.5)
FH and LDL-C not at goal (individual target)60/200 (30.0)
Any of the above153/200 (76.5)
G-BA recommendationn/N (%)
Any of
FH95/199 (47.7)
Non-familial hypercholesterolaemia93/190 (48.9)
Mixed dyslipidaemia84/192 (43.8)
Plus any of
Maximum dietary effort191/191 (100.0)
LDL-C not at goal (individual target)53/91 (58.2)
Statin contraindication86/187 (46.0)
Plus any of
CHD, cerebrovascular disease, PAD or ACS191/191 (100.0)
CV risk factor (diabetes, renal dysfunction)68/191 (35.6)
FH (only) but no further disease or risk0/191 (0.0)
Number of those with at least one of the three categories each191
  • ACS, acute coronary syndrome; ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; CV, cardiovascular; EAS, European Atherosclerosis Society; ESC, European Society of Cardiology; FH, familial hypercholesterolaemia; LDL-C, low-density lipoprotein cholesterol; PAD, peripheral artery disease.